Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Brilliant Usain... ongoing monologue of the bleedin obvious.
That coupled with no punctuation and sometimes completely illegible text other than when copied and pasted.
The latest: “at least the French buyers do not look to be irritated how they loading up again today” easy for anyone to see and at 2.15% up hardly flying.
Shareholder3 puts in a power of work not just on this board but spreads the message across others. Always pleased to see him on here.
at least the French buyers do not look to be irritated how they loading up again today
Sharehunter3 - Please keep it up, as every one is allowed to post.
To be fair, it does get the chat hot. Visibility might help snag some new interest!
I think it's brilliant sharehunter3. The title of the post is going to be seen constantly by everyone so it will attract some attention on the general chat roll.
Can't be bad.
MS
Or preferably not bother at all. It's just an ongoing commentary of what we can all see anyway.
Sharehunter3, could you please start a separate thread for your running commentary on SP and not just jump onto a thread that's discussing the company's future that actually looks beyond the next 5 minutes? Thanks.
Chrishar now up around 2,3 % , moving around like seen on friday
IT'S UP 1.79% SINCE PREVIOUS CLOSE.
maybe its so much take over discussions on different share boards why early morning buying in Paris ,can only guess why early morning buying over there ,
time will answer that question
So, we know that the big boys have acquisition plans, we know they have the money and we know that NCYT could be a prime target. They are the proven player in their own field and have a proven record of innovation, now with the funds to diversify.
Mmmm, now tell me why a T/O isn't a realistic option.....
No hints I’m afraid Usain, we sit and wait and join the dots...
Exactly right! This is just an example of The big Pharma’s Looking to buy up opportunities. In January NCYT may not have been on their radar... but they would be now! Gla
Topprize, that certainly shows the sort of money these boys have set aside for acquisitions. Now, if you were one of those companies, think whether NCYT would be on your radar. Of course it would be, without doubt. It remains a distinct possibility.
Jan 2020
Eli Lilly aims to announce roughly one $1 billion to $5 billion deal every quarter in 2020, its chief financial officer told Reuters, as the U.S. drugmaker looks to build up its pipeline of future products.
It will focus largely on earlier stage opportunities across key therapeutic areas including oncology, pain, immunology, and neurology, CFO John Smiley told Reuters in an interview at the JP Morgan Healthcare conference in San Francisco earlier this week.
https://www.cnbc.com/2020/01/17/eli-lilly-targets-quarterly-deals-of-1-billion-to-5-billion-in-2020-cfo-says.html
Just scanned through this thread and saw someone ask why a big Pharma would pay 1bn for NCYT..
Interestingly I was speaking with my Astra Zeneca neighbour today and he was saying that a number of the big Pharmas spend many billions on just marketing and research!!
Throwing a billion at a profit making company to grow and develop and make part of their own is pocket change to these boys..
Gees Owls you are like a dog with a bone. Of course it's a last resort, its hardly going to be a first resort. 'Sheffield getting enhanced support as it is high on the list of cities at risk of local lockdown'. Basically after Leicester sheffield is 'one of the most ikely' cities To go into local lockdown, likely not definitely. As cases pick up I believe it will, you may believe differently, that's your prerogative.
OBELIX, why do you restrict the list to AIM shares? Believe me there are lots of companies in the main market that are proper investments. Most shares in the AIM market are gambles, as demonstrated by the volatility that they show.
A share that can increase by 9,000% in less than a year and then lose 62% of that gain in the next 2 months is what I would define as a gamble.
BLUELIGHT, you said it is "likely" that Sheffield will go in to a lockdown. The actual statement said it would be a last resort.
flushfrank ,seen in a recent post 20th July , not sure which date results of which percentage of 5bn order each business will win
Worth bearing in mind too that recent director buys have been in the 300-340 range. Whilst they wont necessarily have any additional info, they are obviously happy with that price making them money in the future. Also telling that its been quiet on that front for a month or two. Directors cant buy if news is pending and they are privy to ongoing negotiations etc.
One last thought. I'm not suggesting that this process would have started yesterday, or today. The big boys have acquisitions departments to hunt down buys. NCYT could have been on their radar for months, but yesterday's RNS saw them deliver well before their competitors. Might not have been exactly the RNS you wanted, but it could have been the one they were waiting for. Exciting times, whether it happens or not.
HOLD for me....
Obelix , now back looking at shares again ,often look in at ncyt near end of trading if a rns might be seen close to end of trading
personly happy enough with today got some more today at lower share price than expected ,here with a longer term view ,
T/O is now a very interesting possibility, probably within weeks if it were to happen. That would be a nice RNS to wake up to!
As I say, it's a possibility (although a strong one), rather than probability. Nothing to stop it happening though....
Something's brewing, sure of that.